Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation (Q36176670)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation |
scientific article |
Statements
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation (English)
Wendy Stock
Elizabeth Rich
Olatoyosi Odenike
Lucy A Godley
Peter H O'Donnell
Justin Kline
Vu Nguyen
Paula Del Cerro
9 November 2011
1 reference
1 reference
1 reference
1 reference